Search

5 Jul 2024: Artemis and How Are You? – rapid screening ofmental distress. Background. Mental ill-health (MH) is a global concern that costs UK economy £117.9 billionannually, deepening during the pandemic. Major barriers to addressing thisissue are:. 1.

5 Jul 2024: High energy density lithium-sulfur batteries. Background. Lithium-sulfur batteries have the capability to significantly outperform the state-of-the-art lithium ion batteries currently found on the market. Generatingpower via redox reactions allows Li

5 Jul 2024: Cathode coatings for NMC batteries. Background. It is well established that the capacity of lithium ion cells can be improved byincreasing the proportion of nickel relative to manganese and cobalt in the so-termed NMC cathodes. The lower reliance on

5 Jul 2024: ISOLDE: Building High Quality MacromolecularModels into Low Resolution Experimental Maps. ISOLDE is a ChimeraX plugin (installable via its built-in Tool Shed)designed to ease the task of building high quality macromolecularmodels into low to medium

5 Jul 2024: BloodCounts! an early warning system forinfections outbreaks. Background. The loss of 6.9 million lives in the ongoing COVID-19 pandemic has highlightedthat there is a critical need for simple, affordable, and scalable tools to detectnew emerging

5 Jul 2024: Sparxell. Sparxell. The next generation of colours and effects. Website. The Challenge. Glitters can take many sizes and shapes (from the sequins used in fashion tothe fine powder used in the paint of 1 in 4 cars sold in Europe or found incosmetics)

5 Jul 2024: Early detection of dementia. Background. Diagnosis at early stages of neurocognitive decline has major implications fortimely clinical management. We currently intervene too late and often targetthe wrong patients. With the recent approval of drugs

5 Jul 2024: Wearables for EEG monitoring. Background. Wet EEG electrodes that use an electrolyte gel to form a conductive pathbetween the skin and electrode to reduce the electrode-skin impedanceprovide a good quality EEG signal for only a short duration.

5 Jul 2024: Charged materials for CO2 capture. Background. Current technologies for CO2 capture are based upon organic amines orinorganic hydroxides, but neither is ideal. For example, amines are prone todegradation when regenerated, and are therefore expensive

5 Jul 2024: OSAIRIS: AI cancer imaging tool. Background. Starting radiotherapy promptly improves cancer survival rates and reducesanxiety in newly diagnosed patients. But before any radiotherapy can takeplace, the oncologist must spend a significant amount of

5 Jul 2024: OutSee. OutSee. Discovering novel drug targets using an innovativeAI genomics technology that uncovers disease-modulating biological mechanisms. Website. Overview. OutSee is being launched to take advantage of the opportunity to exploit large-scale

5 Jul 2024: Biophonics. Biophonics. Enabling widespread early detection of valvularheart disease with a unique medical device. Website. Overview. Nearly 2 million people in the UK suffer from significant valvular heart disease,yet more than half remain

5 Jul 2024: PredictImmune. PredictImmune. Helping patients diagnosed with chronic immune-mediated disorders to live normal and healthy lives. Website. Overview. PredictImmune developes prognostic assays that predict disease progressionfor patients with

5 Jul 2024: 360 implant to treat spinal cord injuries. Background. The spinal cord is a key organ of the nervous system, which is in charge ofcarrying information around the body. Every year between 250,000-500,000people suffer injuries to the spinal cord

5 Jul 2024: Real-time autofocus for videomicroscopy. Background. Video-microscopy of living subjects is hampered by their movement out of themicroscope’s focal plane. At video frame-rates, manual refocusing becomesimpossible; therefore, autofocus is required.

5 Jul 2024: Neonatal wireless transmission system. Background. When babies are in intensive care, they need to be continuously monitored.This requires multiple sensors with separate wires. These wires can becometangled and make clinical care harder. Parents

5 Jul 2024: MutREAD – Mutational Signature Detection byRestriction Enzyme-Associated DNA Sequencing. Background. The successful application of mutational signatures in clinical settingsrequires availability of a cost-effective, scalable detection method that

5 Jul 2024: Low-Cost Trace Analyte Detection with ReusableSERS Substrates. Background. To move beyond current low-cost sensors, towards measuring trace analytes inapplications such as healthcare monitoring, geology and mineralogy, pollutionmonitoring, and

5 Jul 2024: Mouse Models of Essential Thrombocythemia (ET)and Myelofibrosis (MF) – Available for PreclinicalStudies. Background. Researchers at the University of Cambridge have generated fully characterised,conditional knock-in mouse models for essential

5 Jul 2024: Implantable drug delivery device targeting braintumours. Background. Successful treatment of brain cancers is limited due to the difficulty ofdelivering therapies to difficult-to-access tumours. There is also a need for newtechnologies able to

5 Jul 2024: Ortho-quinone prodrug strategy (self-immolativelinkers). Background. The para-quinones doxorubicin (Adriamycin),geldanamycin, mitoxantrone and mitomycin C havelower redox-cycling rates than ortho-quinones and aresuccessfully used in the clinic.

5 Jul 2024: Planarific: AI-based software for sustainableretrofitting and design. Background. The UK has set an ambitious goal of achieving net zero carbon emissions by2050, which requires a drastic reduction in the energy consumption andgreenhouse gas

5 Jul 2024: Upcycling waste plastics with sunlight. Background. Traditionally, the term “photoreforming” refers to the use of light energy todrive the conversion of waste feedstocks into sustainable fuels and / orchemicals, such as the production of

5 Jul 2024: Versatile Electronic Fibre. Background. Wearable electronics, such as smart textiles or e-textiles, are growing fields dueto their potential application in healthcare monitoring, consumer electronics,energy harvesting and storage, and sensing. For

5 Jul 2024: Polymer Masterbatch: Customized High-Performance Composite for Your Needs. Background. Nanoparticle composites are a unique class of materials that combine nano-sized particles with a matrix material, creating polymers with new andimproved

5 Jul 2024: Cambridge Centre for Resilience and SustainableDevelopment. Background. At the Centre for Resilience and Sustainable Development CRSD we bringtogether leaders from the public, private and third sectors with academicthought leaders to create robust

5 Jul 2024: Matta. Matta. Building AI to Manufacture the Impossible. Website. Overview. At Matta we are building the AI operating system for additive manufacturing.Our technology is based on state-of-the-art research by engineers andscientists at Cambridge. We

5 Jul 2024: Sustainable Investment Markers Tool: 9SIMS. Background. Lack of integration between environmental, social, and governance (ESG)factors in corporate reporting creates opportunities for greenwashing. This isbecause good performance in one ESG indicator

5 Jul 2024: Phase engineering of 2D materials. Background. 2D materials have many unique properties such as high surface area,exceptional mechanical strength, and excellent electrical and thermalconductivity. Transition metal dichalcogenides (TMDs) e.g.

5 Jul 2024: Cambridge Policy Boot Camp – CPBC. Background. Complex systems theory, political science, sustainability science, andparticipatory research all offer valuable tools and insights for decision makers –but are too often siloed or locked away in

5 Jul 2024: Scalable Production of High-Quality PrintableGraphene. Background. Printable electronics are a promising field of research whose technicaldevelopment is focused on conductive-ink printing technologies appropriate fora wide range of support materials

5 Jul 2024: Blood flow digital twin from a rapid MRI scan. Background. Flow-MRI allows clinicians to visualise flows in the body in 4D (3 spatial and 1time dimension) without using ionising radiation. Currently, scans take tens ofminutes and require the patient

5 Jul 2024: Bamboo cricket bat. Background. This innovative bat combines its high-performance properties with thesustainable credentials which derive from fast growing and widespreadbamboo. DEVELOPED BY RESEARCHERS FROM CAMBRIDGE'S CENTRE FOR NATURAL MATERIAL

5 Jul 2024: Single vessel green ammonia production. Background. Ammonia is the second-largest globally produced chemical ( 240 milliontons/year), mainly used as fertiliser, feeding over 50% of the World’spopulation. Currently, (brown/grey) ammonia is produced

5 Jul 2024: Flexible wooden walls. Background. The way we construct indoor spaces for people is currently flawed. Thepermanence of current buildings limits people’s freedom to change theirsurroundings and restricts their ability to adapt to impermanent ways

5 Jul 2024: H2Upgrade – H2 from industrial waste. Background. Waste generation is a common challenge faced by numerous industries,manifesting as waste gases, liquids, or solid residues from processes, reactions,equipment cleaning, or combustion. The safe

5 Jul 2024: Transforming Pedagogical Practices for AcademicSuccess (TransPAS). Context. China is a multilingual country with over 280 languages spoken by its 56 ethnicgroups. While Mandarin Chinese is promoted as the national lingua franca, thegovernment has

5 Jul 2024: Microparticle production platform technology(DropShell). Background. Engineered microparticles are ubiquitous in many commercial products, fromagritech to nutraceuticals and cosmetics. In the pharmaceutical industry,controlled encapsulation and

5 Jul 2024: Rat CD45 monoclonal antibody YTH 24.5. Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are ratmonoclonal antibodies of the IgG2b isotype. References. 1. C I Bindon, G Hale, M Clark, H Waldmann(November 1985) ,https:/

5 Jul 2024: LGR5 monoclonal antibody for cancerimmunotherapy. Background. In 2020, there were 1.9 million new cases of colorectal cancer, which is the 3rdmost common cancer worldwide. Liver cancer and Leukaemia are the 6th and13th most common cancer types,

5 Jul 2024: MAT2A inhibitors to treat BK polyomavirusdisease. Background. BKPyV is a pervasive human pathogen which resides within the reno-urinarytract in 80-90% of the population. It is asymptomatic in healthy individuals;however, it poses a significant

5 Jul 2024: Electronic nose. Background. This technology “represents a considerable advance in the state-of-the-art…Highly original and building from a sparse amount of previous research”-Prof Krishna Persaud, e-nose pioneer. What would we recognise if

5 Jul 2024: Human CD7 monoclonal antibody YTH 30.15Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are ratmonoclonal antibodies of the IgG2b isotype. CategoryMonoclonal HybridomasCell Lines. Learn more. Explore other available

5 Jul 2024: Human CD59 monoclonal antibody YTH 53.1. Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are ratmonoclonal antibodies of the IgG2b isotype. CategoryMonoclonal HybridomasCell Lines. Learn more. Explore other

5 Jul 2024: Human CD11a monoclonal antibody YTH 81.5. Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are ratmonoclonal antibodies of the IgG2a isotype. CategoryMonoclonal HybridomasCell Lines. Learn more. Explore other

5 Jul 2024: Mouse CD71 monoclonal antibody YTA 74.4.4. Hybridoma cell line producing YTA 74.4.4 antibodies raised against mouse CD71 which aremonoclonal antibodies of the IgG2a isotype. Has been used in CD4 subset depletion in vivo and flowcytometry studies.

6 Mar 2023: Dear Woolf Friends,. It seems our world is becoming an increasinglyunsettled place: Russia’s invasion of Ukraine, globalrefugee numbers increasing to over 100 million,China is flexing its muscles, internally and externally,and peace between

5 Jul 2024: Mouse CD18 monoclonal antibody YTS 213.1.1. Hybridoma cell line producing YTS 213.1.1 antibodies raised against mouse CD18 which are ratmonoclonal antibodies of the IgG2a isotype. CategoryMonoclonal HybridomasCell Lines. Author(s)Herman Waldmann.

5 Jul 2024: Human CD28 monoclonal antibody YTH 913.12. Hybridoma cell line producing YTH 913.12 antibodies raised against human CD28 which are ratmonoclonal antibodies of the IgG2b isotype. CategoryMonoclonal HybridomasCell Lines. Learn more. Explore other

5 Jul 2024: Human CD235a monoclonal antibody YTH 89.1. Hybridoma cell line producing YTH 89.1 antibodies raised against human CD235a which are ratmonoclonal antibodies of the IgG2b isotype. CategoryMonoclonal HybridomasCell Lines. Author(s)Herman Waldmann.